Reckitt Benckiser Group (LON:RB) Price Target Cut to GBX 6,100

Reckitt Benckiser Group (LON:RB) had its price target decreased by stock analysts at Goldman Sachs Group from GBX 6,300 ($82.87) to GBX 6,100 ($80.24) in a report issued on Wednesday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock. Goldman Sachs Group’s target price points to a potential upside of 6.70% from the stock’s previous close.

Several other equities research analysts also recently commented on RB. Deutsche Bank cut their target price on shares of Reckitt Benckiser Group from GBX 7,500 ($98.66) to GBX 7,200 ($94.71) and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Societe Generale dropped their price target on shares of Reckitt Benckiser Group from GBX 5,500 ($72.35) to GBX 5,300 ($69.72) and set a “sell” rating on the stock in a research report on Tuesday, November 26th. Morgan Stanley restated an “overweight” rating and issued a GBX 6,800 ($89.45) price target on shares of Reckitt Benckiser Group in a research report on Sunday, February 9th. UBS Group restated a “neutral” rating on shares of Reckitt Benckiser Group in a research report on Friday, February 21st. Finally, Barclays boosted their price target on shares of Reckitt Benckiser Group from GBX 7,000 ($92.08) to GBX 7,400 ($97.34) and gave the stock an “overweight” rating in a research report on Thursday, January 30th. Four analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of GBX 6,533.53 ($85.94).

LON:RB opened at GBX 5,717 ($75.20) on Wednesday. The firm’s 50 day simple moving average is GBX 6,265.50 and its 200 day simple moving average is GBX 6,142.57. The company has a debt-to-equity ratio of 85.08, a current ratio of 0.59 and a quick ratio of 0.43. Reckitt Benckiser Group has a one year low of GBX 5,510 ($72.48) and a one year high of GBX 8,191.30 ($107.75). The company has a market cap of $41.44 billion and a PE ratio of 28.70.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: What are the benefits of a balanced fund?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.